"We clearly have evidence that obesity is a metabolic imbalance that begins to occur in the mid-30s to mid-40s. Our Cenegenics program is designed to correct the chemistry, which in turn corrects the obesity."
Las Vegas, NV (PRWEB) March 29, 2010
Cenegenics® Medical Institute, global age management medicine leader, continues to champion a proactive medical approach by attacking nutrition and the body’s chemistry as key to a healthier nation. Their protocols are in sync—and actually go well beyond—the current focus on lifestyle modification to reduce obesity and its associated risks, per recommendations from the 2010 National Health and Nutrition Examinations Survey (NANES) and even prevention/wellness initiatives included in President Obama’s newly signed healthcare reform bill.
Recently published on the Journal of the American Medical Association’s website, NANES says adults 40+ have an increased likelihood of becoming obese: 32.2% in men; 35/5% in women. The study recommends doctors becoming more proactive by counseling patients about obesity and associated health risks, encouraging them to become more active. It’s an approach that Cenegenics has taken since its inception. One unique protocol Cenegenics follows is giving patients a hemoglobin A1c test— a diagnostic typically reserved for already diagnosed diabetics to help physicians manage the disease—to better assess the body’s chemistry and identify diabetes risk as well as metabolic disorder.
“We clearly have evidence that obesity is a metabolic imbalance that begins to occur in the mid-30s to mid-40s. Our Cenegenics program is designed to correct the chemistry, which in turn corrects the obesity. We don't attack the obesity as if it is the problem. By attacking the nutrition, we direct patients in a Cenegenics lifestyle with low-glycemic nutrition,” Robert D. Willix Jr., MD said. Willix is the Chief Medical Officer of Cenegenics Las Vegas as well as the Chief Medical Officer/CEO of Cenegenics Boca Raton.
According to Willix, the hemoglobin A1c test reveals how a patient has eaten and, thereby, is directly related to issues of obesity and related health problems.
The hemoglobin A1c test reveals what a person has consumed over the past three months verses a standard blood glucose test, which only measures levels at the time of the test.
Hemoglobin A1c is the level of sugar that’s stuck to a person’s hemoglobin molecules. When looking at the results, doctors can see how well blood sugar levels have been controlled over recent months.
“Cenegenics uses the hemoglobin A1c test proactively—before people become diabetic—as one of the comprehensive blood tests we see associated with cardiovascular disease because of metabolic syndrome and diabetes since it is a precursor to glucose imbalance,” Willix said.
Willix says insulin levels are important for a healthy body. High insulin levels can stop the body from burning off fat, which leads to weight gain. By keeping insulin levels low, the body can utilize stored fat, which is energy, resulting in leanness and a healthier outlook on life.
For more information about Cenegenics, please visit http://www.cenegenics.com. Register for quick access to the informative Guide to Healthy Aging, Executive Summary and NY Times article excerpt. To schedule an interview, please contact Ann Castro, Cenegenics Director of Media Relations: 702.953.1588.
Cenegenics® Medical Institute, recognized leading authority in age management medicine, has centers in Las Vegas, Nevada; Charleston, South Carolina; Boca Raton, Florida; Dallas/Fort Worth, Texas; Atlanta, Georgia; Chicago, Illinois; Los Angeles, California; Philadelphia, Pennsylvania; Washington, DC. Additional centers are scheduled to open in other major metropolitan areas in the near future. With an established presence in the medical community, Cenegenics uses a proactive approach based on solid science and comprehensive evaluation. Their established protocols have been recognized as the next generation of medical science, capturing global attention. Cenegenics offers CME-accredited physician training and certification opportunities in age management medicine via the nonprofit Cenegenics Education and Research Foundation (CERF). Headquartered in Las Vegas, Cenegenics serves more than 20,000 patients worldwide—2,000 are physicians and their families.